311 related articles for article (PubMed ID: 22203543)
1. Prostate cancer screening--the evidence, the recommendations, and the clinical implications.
Chou R; LeFevre ML
JAMA; 2011 Dec; 306(24):2721-2. PubMed ID: 22203543
[No Abstract] [Full Text] [Related]
2. Missing the mark on prostate-specific antigen screening.
Miller DC; Hollenbeck BK
JAMA; 2011 Dec; 306(24):2719-20. PubMed ID: 22203542
[No Abstract] [Full Text] [Related]
3. Grading the new US Preventive Services Task Force prostate cancer screening recommendation.
Volk RJ; Wolf AM
JAMA; 2011 Dec; 306(24):2715-6. PubMed ID: 22203540
[No Abstract] [Full Text] [Related]
4. Prostate cancer screening--time to abandon one-size-fits-all approach?
Kim J; Davis JW
JAMA; 2011 Dec; 306(24):2717-8. PubMed ID: 22203541
[No Abstract] [Full Text] [Related]
5. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
Schröder FH
N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
[No Abstract] [Full Text] [Related]
6. A piece of my mind. Making the call.
Welch HG
JAMA; 2011 Dec; 306(24):2649-50. PubMed ID: 22203530
[No Abstract] [Full Text] [Related]
7. Prostate Cancer Screening - A Perspective on the Current State of the Evidence.
Pinsky PF; Prorok PC; Kramer BS
N Engl J Med; 2017 Mar; 376(13):1285-1289. PubMed ID: 28355509
[No Abstract] [Full Text] [Related]
8. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
Brett AS; Ablin RJ
N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
[No Abstract] [Full Text] [Related]
9. USPSTF finds little evidence to support advising PSA screening in any man.
Slomski A
JAMA; 2011 Dec; 306(23):2549-51. PubMed ID: 22187266
[No Abstract] [Full Text] [Related]
10. Screening for prostate cancer.
Ruffin MT
J Fam Pract; 1999 Aug; 48(8):581-2. PubMed ID: 10496634
[No Abstract] [Full Text] [Related]
11. Screening for prostate cancer remains controversial.
Stark JR; Mucci L; Rothman KJ; Adami HO
BMJ; 2009 Sep; 339():b3601. PubMed ID: 19778971
[No Abstract] [Full Text] [Related]
12. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
[No Abstract] [Full Text] [Related]
14. One man at a time--resolving the PSA controversy.
McNaughton-Collins MF; Barry MJ
N Engl J Med; 2011 Nov; 365(21):1951-3. PubMed ID: 22029758
[No Abstract] [Full Text] [Related]
15. Prostate cancer screening.
Med Lett Drugs Ther; 2008 Nov; 50(1298):85-6. PubMed ID: 18978703
[No Abstract] [Full Text] [Related]
16. Risks of PSA screening now better understood.
Peres J
J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
[No Abstract] [Full Text] [Related]
17. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Ito K
Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
[No Abstract] [Full Text] [Related]
18. Perspective: Enforce the clinical guidelines.
Roobol M
Nature; 2015 Dec; 528(7582):S123. PubMed ID: 26672782
[No Abstract] [Full Text] [Related]
19. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
[No Abstract] [Full Text] [Related]
20. Prostate specific antigen and screening for early prostate cancer.
Davidson P
N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
